|
Q1 2022
Filed on May 10, 2022
|
2,715,000
|
N/A
|
|
|
Q1 2022
Filed on May 10, 2022
|
4,700
|
$30.32 - $91.33
$143K - $429K
|
|
Biomoda Inc Bankrupt Eff 4/14
|
Q1 2022
Filed on May 10, 2022
|
10,000
|
N/A
|
|
|
Q1 2022
Filed on May 10, 2022
|
200
|
$63.11 - $82.31
$12.6K - $16.5K
|
|
|
Q1 2022
Filed on May 10, 2022
|
1,180,000
|
N/A
|
|
|
Q1 2022
Filed on May 10, 2022
|
3,947
|
$43.94 - $52.34
$173K - $207K
|
|
Bns Mxef 10 15 21 20 Buff
|
Q4 2021
Filed on Feb 11, 2022
|
4,955,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
4,355
|
$91.79 - $109.97
$400K - $479K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
12,534
|
$3.5 - $5.68
$43.9K - $71.2K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
27,768
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
8,707
|
$55.87 - $71.04
$486K - $619K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
18,371
|
$29.82 - $36.05
$548K - $662K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
8,588
|
$90.23 - $105.76
$775K - $908K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
3,730,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
9,733
|
$71.8 - $82.75
$699K - $805K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
55,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
8,865,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
3,270,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
7,615,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
55,928
|
$25.76 - $30.28
$1.44M - $1.69M
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
19,827
|
$10.68 - $12.26
$212K - $243K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
19,571
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
12,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
12,000
|
N/A
|
|
Grupo Financiero Banorte Sab D
|
Q4 2021
Filed on Feb 11, 2022
|
13,985
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,634
|
$24.15 - $52.79
$257K - $561K
|
|
Adamas Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 11, 2022
|
667,546
|
N/A
|
|
Hsbc Spx Market Linked Growth
|
Q4 2021
Filed on Feb 11, 2022
|
30,000
|
N/A
|
|
Retail Properties Of America
|
Q4 2021
Filed on Feb 11, 2022
|
27,824
|
N/A
|
|
Ssop LLC Membership Interest A
|
Q4 2021
Filed on Feb 11, 2022
|
1,500,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
85,021
|
$26.25 - $37.05
$2.23M - $3.15M
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,000
|
$0.03 - $0.06
$300 - $600
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
110,903
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
12,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
6,555
|
$32.83 - $43.0
$215K - $282K
|
|
Collateral Loan Security Ban
|
Q3 2021
Filed on Nov 12, 2021
|
79,770
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
353
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,500
|
$43.46 - $53.08
$65.2K - $79.6K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
54,349
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,000
|
$19.72 - $26.38
$59.2K - $79.1K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
360
|
$46.2 - $49.31
$16.6K - $17.8K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
31,075
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,400
|
$46.2 - $49.31
$111K - $118K
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
1,189
|
N/A
|
|
Phillips 66 Partners LP Common
|
Q3 2021
Filed on Nov 12, 2021
|
5,453
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
34,557
|
$26.0 - $27.01
$898K - $933K
|
|
Alliance Bioenergy Plus Inc
|
Q3 2021
Filed on Nov 12, 2021
|
20,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
36,500
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
29,002
|
$15.28 - $18.46
$443K - $535K
|
|